OpenAlex
PricingAboutJobs
Log inGet started
Work

Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers: A Preliminary Study

HTML

Year: 2021
Type: article
Study design: Clinical Trial
Source: Clinical Nuclear Medicine
DOI: 10.1097/rlu.0000000000003810
Authors: Majid Assadi, Seyed Javad Rekabpour, Esmail Jafari, GhasemAli Divband, Babak Nikkholgh, Hamidreza Amini, Hassan Kamali, Sakineh Ebrahimi, Nader Shakibazad, Narges Jokar, Iraj Nabipour, Hojjat Ahmadzadehfar
Institutions: Bushehr University of Medical Sciences, Khatam University, Kharazmi University, Shahid Beheshti University, Shahid Beheshti University of Medical Sciences, Klinikum Westfalen (Germany)
Language: English

Topic: Radiopharmaceutical Chemistry and Applications
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Keywords: fibroblast activation protein, radionuclide therapy, relapsed/refractory cancer, dosimetry, tissue distribution, treatment toxicity, tumor stroma, lutetium-177
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3179223837
FWCI: 9.725
Cites: 29
Cited by: 174
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security